Literature DB >> 9024200

Selective killing of Leishmania amastigotes expressing a thymidine kinase suicide gene.

A Muyombwe1, M Olivier, M Ouellette, B Papadopoulou.   

Abstract

The thymidine kinase gene of Herpes simplex type-1 virus was transfected into several Leishmania species to create drug-sensitive mutants. Expression of the thymidine kinase gene is not by itself harmful to Leishmania cells but it is capable of phosphorylating ganciclovir, a nucleoside analog, into a highly toxic product. In addition to the generation of Leishmania promastigotes highly sensitive to ganciclovir, the thymidine kinase gene was expressed similarly by amastigotes engulfed either by murine or by human macrophages. Leishmania major amastigotes expressing thymidine kinase were eliminated by 85% when treated with ganciclovir. Selective killing of parasites expressing suicide genes at their infective stage could suggest novel strategies for controlling parasitic infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9024200     DOI: 10.1006/expr.1996.4115

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  8 in total

1.  Iron superoxide dismutases targeted to the glycosomes of Leishmania chagasi are important for survival.

Authors:  Katherine A Plewes; Stephen D Barr; Lashitew Gedamu
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

2.  Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues.

Authors:  J Bestman-Smith; I Schmit; B Papadopoulou; G Boivin
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages.

Authors:  C Dumas; M Ouellette; J Tovar; M L Cunningham; A H Fairlamb; S Tamar; M Olivier; B Papadopoulou
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

4.  Development of Vaccines against Visceral Leishmaniasis.

Authors:  Krystal J Evans; Lukasz Kedzierski
Journal:  J Trop Med       Date:  2011-09-05

5.  Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites.

Authors:  Angamuthu Selvapandiyan; Ranadhir Dey; Sreenivas Gannavaram; Ines Lakhal-Naouar; Robert Duncan; Poonam Salotra; Hira L Nakhasi
Journal:  J Trop Med       Date:  2011-09-06

6.  Protective immunity and vaccination against cutaneous leishmaniasis.

Authors:  Ifeoma Okwor; Zhirong Mou; Dong Liu; Jude Uzonna
Journal:  Front Immunol       Date:  2012-05-29       Impact factor: 7.561

Review 7.  Vaccines to prevent leishmaniasis.

Authors:  Rajiv Kumar; Christian Engwerda
Journal:  Clin Transl Immunology       Date:  2014-03-14

8.  Suicidal Leishmania.

Authors:  Lucie Podešvová; Tereza Leštinová; Eva Horáková; Julius Lukeš; Petr Volf; Vyacheslav Yurchenko
Journal:  Pathogens       Date:  2020-01-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.